21 completed, 8 recruiting, 2 active not recruiting, 1 enrolling by invitation. 35 Phase 2, 9 Phase 1, 3 Phase 3.
Follow Spirochaetales Infections: new trials by email Literature Review of Spirochaetales Infections trials Research Report on Spirochaetales Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients VM100 Nutritional Supplement - Duchenne Muscular Dystrophy, Duchenne Disease | Phase 2 | Recruiting | University of Florida | 20 | 2026-07-27 | 2026-10-08 |
| Ceftriaxone for Post-Treatment Lyme Disease Ceftriaxone treatment, Placebo - Post-Treatment Lyme Disease Syndrome | Phase 1 / Phase 2 | Withdrawn | Hackensack Meridian Health | 2026-05-14 | 2026-05-18 | |
| Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis Linezolid (LZD), Amoxicillin, Benzathine Penicillin G - Syphilis, Congenital | Phase 2 | Recruiting | London School of Hygiene and Tropical Medicine | 90 | 2026-05-04 | 2026-10-22 |
| A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age) mRNA-1982, Placebo - Lyme Disease | Phase 2 | Active not recruiting | ModernaTX, Inc. | 366 | 2026-04-29 | 2026-08-03 |
| A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure TP-05 (lotilaner) Low Dose, TP-05 (lotilaner) High Dose, Placebo - Lyme Disease | Phase 2 | Active not recruiting | Tarsus Pharmaceuticals, Inc. | 722 | 2026-03-09 | 2026-07-09 |
| Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil Benzathine penicillin 2.4 million units, Counseling and intensified testing. - Congenital Syphilis | Phase 2 | Recruiting | University of California, Los Angeles | 500 | 2025-09-24 | 2026-06-01 |
| N-Acetylcysteine in Patients With Leptospirosis N-acetylcysteine, Placebo - Leptospirosis | Phase 2 | Completed | Dr Cipto Mangunkusumo General Hospital | 64 | 2025-08-30 | 2026-09-16 |
| Daily Doxycycline for Early Syphillis Doxycycline 200mg daily for 14 days - Syphilis | Phase 2 | Recruiting | University of Washington | 15 | 2025-03-03 | 2025-06-25 |
| Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Lumbrokinase - Long Covid, Post-treatment Lyme Disease Syndrome | Phase 1 / Phase 2 | Recruiting | Icahn School of Medicine at Mount Sinai | 120 | 2024-10-09 | 2026-03-13 |
| Peer Delivered HIV/Syphilis Self-Testing With Assisted Partner Notification Services Peer distribution of self testking kits - HIV, Syphilis | Phase 2 | Enrolling by invitation | Makerere University | 200 | 2024-08-25 | 2025-01-24 |
| Vasodilator and Exercise Study for DMD (VASO-REx) Tadalafil, Placebo, Exercise Training - Duchenne Muscular Dystrophy, Duchenne Disease | Phase 2 | Recruiting | University of Florida | 50 | 2024-06-05 | 2026-05-15 |
| Preventive Strategies for Early and Late Complications of Leptospirosis Prophylactic Plasma Transfusion, Hemoperfusion, Extracorporeal Membrane Oxygenation - Leptospirosis | Phase 2 | Recruiting | National Kidney and Transplant Institute, Philippines | 678 | 2024-04-12 | 2026-04-13 |
| Linezolid for Syphilis Pilot Study Group B, Linezolid 10d, Group A, Penicillin - Syphilis | Phase 2 | Completed | University of Southern California | 24 | 2023-09-28 | 2026-11-04 |
| A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age mRNA-1975, mRNA-1982, Placebo - Lyme Disease | Phase 1 / Phase 2 | Completed | ModernaTX, Inc. | 807 | 2023-07-26 | 2026-07-30 |
| A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05 Low Dose TP-05, High Dose TP-05, Placebo Comparator - Healthy Volunteer | Phase 2 | Completed | Tarsus Pharmaceuticals, Inc. | 30 | 2022-12-12 | 2024-09-19 |
| Tetracycline Treatment Tolerability Trial Tetracycline 500 Mg, Placebo - Post-Treatment Lyme Disease | Phase 2 | Completed | Johns Hopkins University | 60 | 2022-11-02 | 2026-09-28 |
| Human Immune Response to Ixodes Scapularis Tick Bites Xenodiagnosis Ticks, skin biopsy, blood draw - Tick-borne Diseases, Tick Resistance | Phase 1 / Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 60 | 2022-02-28 | 2026-09-22 |
| Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population VLA15, Placebo - Lyme Borreliosis | Phase 2 | Completed | Pfizer | 625 | 2021-03-08 | 2026-09-15 |
| A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome RLP, Placebo - Post-Lyme Disease Syndrome (PLDS) | Phase 2 / Phase 3 | Completed | Optimal Health Research | 100 | 2019-11-29 | 2021-04-12 |
| Trial Evaluating the Clinical Efficacy of Cefixime for Treatment of Early Syphilis in Non-pregnant Women Cefixime, Benzathine penicillin 2.4 million units - Syphilis Female | Phase 1 / Phase 2 | Unknown | World Health Organization | 180 | 2019-11-22 | 2020-02-05 |
Showing 20 of 35. Sign in to see all of them.
Lyme Disease (12) · Syphilis (9) · Post-Lyme Disease Syndrome (6) · HIV Infections (4) · Borrelia Infections (3) · Leptospirosis (3) · Sexually Transmitted Diseases (3) · Chlamydia Infections (2) · Fatigue (2) · Gonorrhea (2) · Muscular Dystrophies (2) · Muscular Dystrophy, Duchenne (2) · Syphilis, Congenital (2) · Tabes Dorsalis (2) · Tick-Borne Diseases (2)
Bacterial Infections (34) · Bacterial Infections and Mycoses (34) · Gram-Negative Bacterial Infections (34) · Infections (34) · Vector Borne Diseases (17) · Tick-Borne Diseases (15) · Borrelia Infections (14) · Treponemal Infections (14) · Pathological Conditions, Signs and Symptoms (11) · Pathologic Processes (10) · Urogenital Diseases (10) · Communicable Diseases (9) · Disease Attributes (9) · Genital Diseases (9)
Cefixime (2) · Linezolid (2) · Methods (2) · Penicillin G (2) · lotilaner (2) · Acetylcysteine (1) · Albendazole (1) · Amoxicillin (1) · Azithromycin (1) · Blood Specimen Collection (1) · Ceftriaxone (1) · Counseling (1) · Deamino Arginine Vasopressin (1) · Dexamethasone (1) · Diethylcarbamazine (1)
Pfizer (3) · ModernaTX, Inc. (2) · Optimal Health Research (2) · Population Council (2) · Tarsus Pharmaceuticals, Inc. (2) · University of California, Los Angeles (2) · University of Florida (2) · Centers for Disease Control and Prevention (1) · Dr Cipto Mangunkusumo General Hospital (1) · Hackensack Meridian Health (1) · Icahn School of Medicine at Mount Sinai (1) · Johns Hopkins University (1) · Lihir Medical Centre (1) · London School of Hygiene and Tropical Medicine (1) · Mahidol University (1)
United States (21) · Brazil (2) · Indonesia (2) · Papua New Guinea (2) · South Africa (2) · Thailand (2) · Belgium (1) · Canada (1) · Germany (1) · Israel (1) · Malawi (1) · Philippines (1) · Switzerland (1) · Uganda (1)
Jeffrey D Klausner, MD MPH (2) · Adriana R Marques, M.D. (1) · Barbara A Castelnuovo, MD, MPH. PhD (1) · Bindu Balani, MD (1) · Brian A Fallon, MD (1) · Brian Fallon, M.D. (1) · Bridget Freyne (1) · Charlotte E. Ellertson, MPA, Ph.D. (1) · David Putrino, PhD, PT (1) · David Tellalian, MD (1) · Edna O Kara, MD (1)
PMID 38830375, PMID 16837678, PMID 32522244, PMID 32818264, PMID 33298143, PMID 33640982, PMID 37262040, PMID 39029481, PMID 40265182, PMID 40294611, PMID 41213278, PMID 42086599, PMID 42680745, PMID 42848323
R01AI045468 (1), R01AI187414 (1), R01MH092226 (1), R21AR079755 (1)